In the published article, there was an error in the author list order. When author Anna Marie Mulligan was added, she was erroneously listed as the final author when that position should have been for the primary investigator, Alla Reznik.
The correct author list and affiliations should be:
"Madeline Rapley1 *, Vivianne Freitas 2, Irving N. Weinberg3, Brandon Baldassi 4, Harutyun Poladyan1, Michael Waterston 4, Sandeep Ghai 2, Samira Taeb5, Oleksandr Bubon1,4, Anna Marie Mulligan6 and Alla Reznik1,7."
"1 Department of Physics, Lakehead University, Thunder Bay, ON, Canada, 2Temerty Faculty of Medicine, Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada, 3Weinberg Medical Physics, Rockville, MD, United States, 4Radialis Inc., Thunder Bay, ON, Canada, 5Department of Research, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, 6 Laboratory Medicine Program, University Health Network – Toronto General Hospital Site, University of Toronto, Toronto, ON, Canada, 7Thunder Bay Regional Health Sciences Centre, Thunder Bay, ON, Canada."
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
low-dose positron emission mammography, organ-targeted positron emission tomography, breast MRI, high specificity breast imaging, breast cancer overdiagnosis with MRI
Citation
Rapley M, Freitas V, Weinberg IN, Baldassi B, Poladyan H, Waterston M, Ghai S, Taeb S, Bubon O, Mulligan AM and Reznik A (2024) Corrigendum: Case report: Possible role of low-dose PEM for avoiding unneeded procedures associated with false-positive or equivocal breast MRI results. Front. Oncol. 14:1477862. doi: 10.3389/fonc.2024.1477862
Received
08 August 2024
Accepted
11 September 2024
Published
25 September 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2024
Updates
Copyright
© 2024 Rapley, Freitas, Weinberg, Baldassi, Poladyan, Waterston, Ghai, Taeb, Bubon, Mulligan and Reznik.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Madeline Rapley, mdrapley@lakeheadu.ca
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.